YESAFILI
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Sept 2025)
What this means for you
This application is over — abandoned 29 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90879797
- Mark type
- Stylized text
- Filed
- 12 Aug 2021
- Published for opposition
- 28 Jun 2022
- Abandoned
- 29 Sept 2025
- Attorney of record
- Bentley J. Olive
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of ophthalmic conditions
Owner
- Biosimilars Newco Limited, Hertfordshire, GB
- MYLAN INC., CANONSBURG, PA, US
- Mylan Pharmaceuticals Inc., Morgantown, WV, US
- Mylan Pharmaceuticals Inc., Morgantown, WV, US
Prosecution history
- 29 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 5 GRANTED
- 18 Feb 2025 — SOU EXTENSION 5 FILED
- 18 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2024 — SOU EXTENSION 4 GRANTED
- 20 Aug 2024 — SOU EXTENSION 4 FILED
- 20 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2024 — SOU EXTENSION 3 FILED
- 23 Feb 2024 — SOU TEAS EXTENSION RECEIVED
- 03 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2023 — SOU EXTENSION 2 GRANTED